Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT04313504 · ClinicalTrials.gov registry record · Phase 2

Study Evaluating the Efficacy of Niraparib and Dostarlimab (TSR-042) in Recurrent/Metastatic HNSCC

A Phase 2 study of Head and Neck Cancer, sponsored by Trisha Wise-Draper.

Active
Registry status
Phase 2
Development phase
23
Enrollment target
1
Study location

NCT04313504 is a Phase 2 study of Head and Neck Cancer that is active but no longer recruiting, run by Trisha Wise-Draper. The registered enrollment target is 23 participants, below the 261-participant average among 250 other Head and Neck Cancer trials with a reported enrollment target (91% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT04313504, a Phase 2 study of Head and Neck Cancer, is active but no longer recruiting, sponsored by Trisha Wise-Draper.

ACTIVE NOT RECRUITING
Registry status
Phase 2
Development phase
23 participants
Enrollment target
1
Study location

Study Summary

The purpose of this study is to determine the best overall response of the combination of dostarlimab and niraparib in patients with recurrent and/or metastatic HNSCC patients.

Conditions Studied

Head and Neck Cancer

Interventions

  • DRUG Niraparib
  • DRUG Dostarlimab

Study Locations (1)

Ohio

  • University of Cincinnati Medical Center - Cincinnati

Trial Details

FieldValue
Enrollment Target 23 participants
Start Date 2020-11-04
Est. Completion 2025-06-01
Phase Phase 2

Sponsor

Trisha Wise-Draper

6 total trials

Interested in This Trial?

Full Details on ClinicalTrials.gov ↗

What the Registry Record Tells You About NCT04313504

The ClinicalTrials.gov registry entry for NCT04313504 describes a study currently listed as active not recruiting, categorized as Phase 2. The registered enrollment target is 23 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 261-participant average among 250 other Head and Neck Cancer trials with a reported enrollment target (91% lower). The listed sponsor is Trisha Wise-Draper, which has 6 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Head and Neck Cancer appearing as the primary indexed condition, and to 2 interventions - of which Niraparib is the first listed.

NCT04313504 reports 1 study location spanning 1 distinct geographic area - top geographies include Ohio.

Frequently Asked Questions

What is clinical trial NCT04313504 about?

NCT04313504 is a clinical study titled "Study Evaluating the Efficacy of Niraparib and Dostarlimab (TSR-042) in Recurrent/Metastatic HNSCC". The purpose of this study is to determine the best overall response of the combination of dostarlimab and niraparib in patients with recurrent and/or metastatic HNSCC patients.

What is the current status of trial NCT04313504?

This trial is currently active not recruiting. It is a Phase 2 study. The enrollment target is 23 participants. The study started on 2020-11-04. Estimated completion is 2025-06-01.

What conditions does trial NCT04313504 study?

This clinical trial studies the following conditions: Head and Neck Cancer.

What interventions are being tested in trial NCT04313504?

The interventions under investigation include: Niraparib (DRUG), Dostarlimab (DRUG).

Who is sponsoring clinical trial NCT04313504?

This trial is sponsored by Trisha Wise-Draper, which has 6 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT04313504 being conducted?

This trial has 1 study location across Ohio. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Learn More About Clinical Trials

Similar trials for Head and Neck Cancer

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Explore more on PlainTrial

Head and Neck Cancer

All registered trials for this condition

Ohio

All trials with a study site in Ohio

Recruiting now

Find trials open to new participants near you

Rankings

Top sponsors, conditions, and phases

Read our methodology - how this data is sourced, computed, and verified.

Related

Browse all → | Rankings →
Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.